Nanomedicine News

RSS

Universities Receive $3 Million from NSF for Nanotechnology and Materials Research

Xavier University of Louisiana and New York University have received a $3 million grant from the National Science Foundation to bolster diversity among materials scientists through collaborative research and curriculum d...

9 Sep 2009

Convention Focuses on Important Issues Surrounding Quality of Food and Drugs

Important issues surrounding the quality of food and drugs-including global supply chain management, the challenges of creating follow-on biologics (in Canada, subsequent entry biologics) and nanotechnology for drug deli...

9 Sep 2009

Professor Receives NSF CAREER Award for Nanotechnology Research

Diana-Andra Borca-Tasciuc, assistant professor of mechanical, aerospace, and nuclear engineering at Rensselaer Polytechnic Institute, has won a Faculty Early Career Development Award (CAREER) from the National Science Foundation (NSF).

9 Sep 2009

Drug Development Based on RNA Interference

Putting the next generation of medicines on pharmacy shelves hinges on an intensive search for ways of safely and effectively delivering a silencing message to genes that are at the basis of innumerable diseases. That&#3...

9 Sep 2009

Nanoparticles "Seek and Destroy" Brain Cancer Cells

In an advance toward better treatments for the most serious form of brain cancer, scientists in Illinois are reporting development of the first nanoparticles that seek out and destroy brain cancer cells without damaging nearby healthy cells.

9 Sep 2009

Nanotechnology Researcher Awarded $2.3 Million for Cancer Research

A University of Arkansas for Medical Sciences (UAMS) researcher on the cutting edge of nanotechnology has been awarded $2.3 million in three grants to further groundbreaking developments in the prevention of lethal cance...

8 Sep 2009

NanoBio to Present Studies at ICAAC 2009

NanoBio Corp. announced today that data from a large ferret study indicates that its intranasal, nanoemulsion-based adjuvant elicits robust immunity and cross protection against influenza using 1/15th of the standard antigen dose, without evidence of toxicity or tolerability concerns.

From BlueWillow Biologics 8 Sep 2009

New Program Offers an Extensive Assortment of Protein Array Services

NanoInk, Inc.®, a global leader in nanotechnology, is pleased to announce the launch of a Contract Research Program as part of its Nano BioDiscovery™ Division. Based on the patented Dip Pen Nanolithography® (DPN®) platform, NanoInk's contract services provide miniaturization and multiplex protein analysis.

From Veeco 8 Sep 2009

NanoViricides CEO to Speak Bbout Rapid Drug Development Enabled by Nanoviricides Technology at NanoBusiness2009 Conference

NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that Anil Diwan, PhD, President of the Company has been asked to present a talk at NanoBusiness2009 - the 8th annual NanoBusiness Conferenc...

From NanoViricides, Inc 8 Sep 2009

Researchers Make Breakthrough in Direct-Method Research on Protein Crystallography

Recent years have witnessed advances in direct-method research on protein crystallography obtained by the research team led by Academician Fan Haifu from the Institute of Physics, Chinese Academy of Sciences (CAS).

8 Sep 2009